1. Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis. (23rd October 2013) Authors: Gironi, M.; Solaro, C.; Meazza, C.; Vaghi, M.; Montagna, L.; Rovaris, M.; Batocchi, A. P.; Nemni, R.; Albertini, R.; Zaffaroni, M.; Bozzola, M. Other Names: Geurts Jeroen Academic Editor. Journal: Multiple sclerosis international Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. Issue 1 (December 2016) Authors: Realdon, O.; Rossetto, F.; Nalin, M.; Baroni, I.; Cabinio, M.; Fioravanti, R.; Saibene, F.; Alberoni, M.; Mantovani, F.; Romano, M.; Nemni, R.; Baglio, F. Journal: BMC psychiatry Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The evoked potentials score improves the identification of benign MS without cognitive impairment. Issue 10 (7th January 2013) Authors: Margaritella, N.; Mendozzi, L.; Tronci, F.; Colicino, E.; Garegnani, M.; Nemni, R.; Gilardi, E.; Pugnetti, L. Journal: European journal of neurology Issue: Volume 20:Issue 10(2013:Oct.) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗